APA

Wang J., Udd K. A., Vidisheva A., Swift R. A., Spektor T. M., Bravin E., Ibrahim E., Treisman J., Masri M. & Berenson J. R. (20171006). Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy. : Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.

Chicago

Wang James, Udd Kyle A, Vidisheva Aleksandra, Swift Regina A, Spektor Tanya M, Bravin Eric, Ibrahim Emad, Treisman Jonathan, Masri Mohammed and Berenson James R. 20171006. Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy. : Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.

Harvard

Wang J., Udd K. A., Vidisheva A., Swift R. A., Spektor T. M., Bravin E., Ibrahim E., Treisman J., Masri M. and Berenson J. R. (20171006). Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy. : Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.

MLA

Wang James, Udd Kyle A, Vidisheva Aleksandra, Swift Regina A, Spektor Tanya M, Bravin Eric, Ibrahim Emad, Treisman Jonathan, Masri Mohammed and Berenson James R. Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy. : Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 20171006.